Medpace builds up in Scotland; Chinese CRO market primed to pop, report says;

> Medpace has tripled the size of its outpost in Scotland, adding a new office to focus on data management, biostatistics and regulatory affairs. More

> The Chinese CRO market will grow to $13.6 billion in 2018 from just $6.6 billion in 2014, according to a report from Research and Markets. Item

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.